-
Michael Halloran March 9, 2021
President Biden’s stimulus bill is set to become law this week after the Senate passed the amended bill on Saturday with only marginal changes.
-
Michael Halloran February 16, 2021
Stocks made record highs again last week and continue to benefit from better-than-expected corporate profits, lower COVID infection rates, an accelerating vaccine rollout, and the promise of additional fiscal stimulus from the Biden administration.
-
Michael Halloran February 8, 2021
Improving business surveys, good news on lower infection rates, potential additional vaccine manufacturers, and better-than-expected corporate profitability support our positive outlook for 2021.
-
Michael Halloran February 1, 2021
Market volatility increased last week with stocks having their worst week since October and finishing down for the month of January.
-
Michael Halloran January 25, 2021
Housing and manufacturing conditions suggest a sustainable economic recovery remains in place, despite the surging virus and the impact it is having on consumer’s ability to spend.
-
Michael Halloran January 20, 2021
Stocks had their worst week since October last week, with the economic data showing the effects of renewed restrictions as the virus surge continues and as the effects of last spring’s massive CARES Act stimulus wanes.
-
Michael Halloran January 11, 2021
Stocks started the new year on an optimistic note with the S&P 500, Dow Jones Industrials, Nasdaq Composite, and the small-cap Russell 2000 all making record highs last week.
-
Michael Halloran January 4, 2021
Stocks finished 2020 on a positive note, looking past the continued spread of the virus and instead focusing on the positive news about vaccine development and distribution and the unprecedented monetary and fiscal stimulus.
-
Michael Halloran December 28, 2020
Stocks are rising after President Trump signed the coronavirus relief and full-year government funding package into law.
-
Michael Halloran December 21, 2020
With the virus still surging with associated economic headwinds, lawmakers have agreed to a roughly $900 billion follow-on COVID-19 relief package designed to further bridge the economy through this extraordinary period.
-
Michael Halloran December 14, 2020
The rollout of Pfizer’s vaccine, which should be followed shortly by Moderna’s and others, is allowing the market and business leadership to focus on economic normalization as we move through 2021.
-
Michael Halloran November 30, 2020
The Dow Jones Industrial Average, S&P 500, and Nasdaq Composite stock indexes all made record highs last week.
-
Michael Halloran November 24, 2020
Stocks continue to focus on a post-pandemic environment despite the high infection rate and new shutdowns that present near-term headwinds to economic activity.
-
Michael Halloran November 16, 2020
While the number of COVID-19 cases continues to rise and remains a concern, the S&P 500 stock index gained 2.2% to an all-time high last week.
-
Michael Halloran November 9, 2020
While President-elect Biden moves ahead with his transition plan to the White House, the January 5th Georgia Senate runoffs remain important for future policy developments.
-
Michael Halloran November 2, 2020
Stocks sold off last week as COVID-19 cases spiked in the U.S. and Europe, renewed lockdowns were announced across Europe, and uncertainty around the timing of stimulus and the election outcome continued.
-
Michael Halloran October 26, 2020
While market concerns center on stimulus talks, election uncertainty, and rising COVID-19 cases, we remain encouraged by the incoming economic readings.
-
Michael Halloran October 19, 2020
Despite stalled stimulus talks and a stubbornly resilient virus, we remain optimistic on the outlook for stocks and other risk assets.
-
Michael Halloran October 12, 2020
Stocks posted another healthy week of gains and the September market drawdown has mostly been erased over the past three weeks.
-
Michael Halloran October 5, 2020
While the President’s health, the upcoming election, and additional fiscal support are all presenting uncertainty for the market, the incoming economic data continues to support our positive recovery narrative.